[DOI] [PMC free article] [PubMed] [Google Scholar] 109.Konstan M.W., Doring G., Heltshe S.L., Lands L.C., Hilliard K.A., Koker P., Hattacharya S., Staab A., Hamilton A., Investigators and Coordinators of BI Trial 543.45 A randomized double blind, placebo-controlled phase 2 trial of BIIL 284 BS (an LTB4 receptor antagonist) for the treatment of lung disease in children and adults with cystic fibrosis
Insights Pediatr
Cells 8 , 1224 (2019)
Instead of just treating one spot, the IV distributes nutrients to every inch of your skin, ensuring that your arms, neck, and face all benefit from the same brightening effect
10.7860/JCDR/2014/7966.4002 J Clin Diagn Res
Does the Mediterranean G6PD S188F Polymorphism Confer Vascular Protection